HopeStage
Back to all studies
CompletedNCT05343039

Digital support and nerve stimulation for teen self-harm and alcohol use

About this titleRead the official source — NCT05343039
Device studyAges 13–17United StatesSuicide prevention
The study in practice

Understand this study

Who was this study for?

Listed age limits: 13 years to 17 years.

Listed locations
South BendSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 6, 2022
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
University of Notre Dame
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 13 Years to 17 Years
Official registry ID
NCT05343039
Official title
Show the full official title

Leveraging Biomarkers and New Technologies to Reduce Self-Injury and Substance Abuse Risk Among Highly Vulnerable Adolescents

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

South Bend

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Notre Dame, a university.

Who was this study for?

Listed age limits: 13 years to 17 years.

Want to explore more studies?

Explore studies